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Abstract
Objectives: To translate the Pediatric Asthma Quality of Life Questionnaire (PAQLQ) into Portuguese and adapt
it to the Brazilian context, for use in children and adolescents with asthma and to validate the adapted version of
the questionnaire (PAQLQ-A).
Methods: Children and adolescents (7 to 17 years old) with asthma answered the PAQLQ-A on admission and
were assessed using a clinical severity score. According to this score, patients were classified as mild (< 2) or
moderate/severe (> 2). They were reassessed on at least two occasions at an interval of 2 to 4 weeks. Furthermore,
patients in whom asthma was properly controlled were classified as stable, and those in whom it could not be
controlled, as unstable.
Results: The reproducibility of the PAQLQ-A was evaluated in stable patients by comparing the mean domain
scores: symptoms, emotions, activities, and the overall clinical severity score on two predefined occasions with an
interval of 15 to 30 days in between. Responsiveness was evaluated among unstable patients. The mean domain
scores and the overall score were different on both occasions, and so was the clinical severity score. The validity
of the questionnaire was determined by the application of Cronbachs alpha reliability coefficient (α = 0.909).
Conclusions: The translation of the PAQLQ into Portuguese did not modify the framework of the original
questionnaire; the PAQLQ-A is easy to use, with easy reproducibility, constituting a valuable instrument for the
evaluation of the quality of life in children and adolescents with asthma.
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Introduction
In cases of chronic diseases such as asthma, criteria that
allow for a thorough and comprehensive assessment and
which do not only consider treatment, but also the complex
ORIGINAL ARTICLE
nature of individuals, the disease and the relationship
between them,1 have been increasingly used.
Until recently, the main concern with asthma was
related to the treatment of asthma attacks and their
different severities, as well as to the prevention of
recurrent episodes with environmental measures and
drug therapy. With the advent of new and long-acting
inhaled drugs, the prognosis of asthma has remarkably
improved. Because of that, nowadays, our concern is to
allow our asthmatic patients to lead a better life and
improve their quality of life (QoL) day after day.
QoL varies among people, according to their
expectations about the disease and about their life, and
these expectations may change with time according to the
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experiences undergone throughout the years.2 QoL is
determined by the perceptions of individuals about their
status in life, in the cultural context (system of values) in
which they are inserted and in the relationship of ideals,
expectations, standards and worries, which change in
response to the disease.2
In children, QoL used to be based on the conventional
assessment of asthma severity, on pulmonary function
testing, on the presence and intensity of the symptoms, on
the need for medication and for discussion with the parents.3
However, today, ample evidence exists that clinical
parameters have a weak correlation with what a child is
feeling and with how his/her daily functions are.3 Some
authors have described that parents may not appropriately
perceive the QoL in their asthmatic children.3,4
Written questionnaires (WQ) have been the major tools
for the assessment of QoL, and can be either general or
disease-specific.5,6 In general, disease-specif ic
questionnaires have been more widely used since they are
more sensitive and able to detect minimum changes in the
health-related QoL of these patients.5,7-11
The Asthma Quality of Life Questionnaire (AQLQ) was
one of the first WQ to be used in the assessment of QoL of
adult asthmatic patients.12 Based on clinical experience
with the AQLQ and its adaptations, Juniper et al.13 developed
the Pediatric Asthma Quality of Life Questionnaire (PAQLQ),
which was validated and published originally in English in
1996 and in other 20 languages after that.3,14-18
The PAQLQ consists of 23 questions (items) divided into
three categories (domains): activity limitations (five
questions), symptoms (10 questions) and emotional function
(eight questions). With regard to physical activities, patients
themselves select three of the activity limitation items. The
answers, similarly to what occurs in the AQLQ, are assessed
by way of a seven-point scale, where 1 indicates maximum
impairment and 7, no impairment.13
After choosing the tool, it is important to make sure it
has some properties so that it can be properly applied. It
should therefore be valid, able to detect changes and it has
to be reproducible.
The aims of the present study were to translate the
PAQLQ into Brazilian Portuguese and adapt it for use in
asthmatic children and adolescents; to check its validity,
reproducibility and responsiveness to the adapted version
of the questionnaire (PAQLQ-A).
Patients and methods
Patients
The study included children and adolescents aged
between 7 and 17 years old (n = 56, 25 female individuals)
regularly registered and treated at the Outpatient Clinic
of Allergy, Department of Pediatrics of Universidade
Federal de Sªo Paulo (UNIFESPEPM), from May 2002 to
December 2003. All patients with intermittent or persistent
asthma were selected, based on the definition and
classification of disease severity of the Third Brazilian
Consensus on the Management of Asthma.19 Patients
with history of recurrent pulmonary infection or with
chronic disease that could interfere with the assessment
of QoL, and those treated with systemic corticosteroids in
the past two weeks or who refused to participate were
excluded from the study. Based on the original study, we
included at least 52 patients, since the original PAQLQ
was validated with a similar number of patients.13
After admission, the patients were interviewed at
predefined times: on admission, 15 days after inclusion, 30
days after the second and third interviews (we included an
additional interview, compared with the original study, for
validation of the PAQLQ).13 Besides clinical evaluation, the
patients were submitted to pulmonary function testing:
forced vital capacity (FVC), forced expiratory flow between
25-75% of the FVC (FEF 25-75%) and forced expiratory
volume in first second (FEV1) before and after bronchodilator
use (Vitatrace VT  130).
In each appointment, patients were assessed in terms
of their clinical stability and proper use of medications.
With these data, we established a clinical severity score
(CSS): presence of nighttime symptoms, presence of
daytime symptoms, use of inhaled ß-2 agonists more than
twice a day, daily activity limitation, presence of
expectoration, and FEV1 below 80% of the predicted
value.13,20 The same score had been used by Juniper et
al. for the validation of the PAQLQ in order to determine
which patient had inadequately controlled asthma.13
However, FEV1 instability was less than 70% of the
predicted value for these authors after bronchodilator
use. Each item of the CSS was assigned one point and,
according to the total sum (maximum = 6), the patients
were classified as mild (< 2) or moderate/severe (> 2).
Besides this classification, the patients were assessed in
terms of their clinical stability and were then subdivided
into: stable (those remaining in the same CSS group) and
unstable (those who changed groups, turning from mild into
moderate/severe or vice versa).
All patients, as well as their parents and/or surrogates,
were informed about the aims of the study. All those who
agreed to participate signed an informed consent form. The
study protocol was approved by the Ethics and Research
Committee of UNIFESP  EPM.
PAQLQ - adapted (PAQLQ-A)
The PAQLQ was initially translated into Brazilian
Portuguese, and then translated back into English by a
language teacher who was not familiarized with the
questionnaire. No discrepancy was observed between the
original WQ and the translated version.
After being translated, the questionnaire was
experimentally applied (pre-questionnaire) to 20 patients
with (intermittent or persistent) asthma aged between 7
and 16 years old (mean 9.9–2.7 years), 13 of whom were
male. After this assessment, five activities contained in
the original WQ were removed for they are not part of the
Brazilian culture (ball hockey, American football, skiing,
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baseball and ice-skating). The other items were maintained
according to the translation, but were organized in an
order that facilitated its application (Figure 1 ). The new,
translated and adapted questionnaire was called Pediatric
Asthma Quality of Life Questionnaire  Adapted (PAQLQ-
A) and the same scoring system (1 to 7) as that used in
the original questionnaire.
Assessment of PAQLQ-A properties
The reproducibility of the questionnaire was evaluated
at two different times (at an interval of 15 to 30 days), by
the same observer, in stable patients. Both stable and
unstable patients were used to check the validity of the
questionnaire, also at two different times (at an interval
of 15 to 30 days). Responsiveness was assessed by the
variation of clinical parameters between two defined
times and between the two groups analyzed (stable and
unstable). In addition, consistency and reliability were
calculated by the mean score for each of the domains and
for each question separately.
Statistical analysis
After being collected, the data were exported to EXCEL
2000 and the statistical analyses were made using SPSS
11.0, INSTAT and Epi-Info 6.04. The following tests were
used: chi-square test, Fishers exact test, Wilcoxons
signed-rank test, Mann-Whitney test, Spearmans
correlation test and Cronbachs alpha reliability coefficient.
Results
Of the 75 initially admitted patients, 56 were assessed
at least twice at different times. Nineteen patients were
excluded for missing their follow-up appointment (n =
14), or because they could not understand the questions
(n = 5). Patient characteristics are shown in Table 1.
There was a male predominance (54.4%) and age ranged
from 7 to 17 years (mean of 11.4–2.1 years). Eight-six
percent of them had persistent asthma and 14%
intermittent asthma, with no significant differences
between male and female patients. Among asthma-related
diseases, 96.4% presented allergic rhinitis (Table 1). The
use of inhaled corticosteroid was reported by 32 patients
(57.8%) in their first medical appointment, with no
difference between male and female patients (Table 1).
Thirty-four patients (60.7%) were submitted to four
interviews, 11 to two (19.6%) or three (19.6%) interviews
at different times (Table 1), totalizing 191 assessments.
However, during follow-up, several patients changed
their asthma stability and were classified as stable or
unstable at some time, thus, in the final assessment, 50
Table 1 - Demographic characterisitics of patients with asthma submitted to PAQLQ-A (n = 56)
Variables Sex Total Statistical p
Male (%) Female (%) test
Sex 31 (55.4) 25 (44.6) 56
Mean age 11.7 years 11.2 years 11.4 years
 (standard deviation) (–1.8) (–2.4) (–2.1)
Age < 12 years 18 16 34 (60.7%) χ† = 0.04 0.842
Age > 12 years 13 9 22 (39.3%)
Clinical classification
Stable 28 22 50 (69.4%) χ† = 0.120 0.730
Unstable 14 8 22 (30.6%)
Intermittent asthma 3 5 8 (14.3%)
Mild persistent 7 1 8 (14.3%)
Moderate persistent 21 17 38 (67.8%)
Severe persistent 0 2 2 (3.6%)
Associated diseases
Allergic rhinitis 30 24 54 (96.4%) Fisher 0.697
Allergic conjunctivitis 6 3 9 (15.8%)
Atopic dermatitis 2 2 4 (7.0%)
Hives 1 0 2 (3.5%)
Contact dermatitis 0 1 1 (1.7%)
Food allergy 0 0 0
Previous use of corticosteroid 15 17 32 (57.8%) χ† = 1.45 0.113
Number of interviews
Four 22 12 34 (60.7%) χ† = 3.01 0.083
Three 4 7 11 (19.6%) Fisher 0.077
Two 5 6 11 (19.6%) Fisher 0.342
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patients (69.4%) were regarded as stable at some time
during the study and 23 (30.6%) as unstable, with no
difference between male and female patients (Table 1).
In terms of reproducibility, stable patients were compared
as to the mean score for each of the domains (MD):
symptoms (MSD), emotional function (MED), activity (MAD)
and overall score, and the CSS, at two different times TA and
TB (at intervals of 15 to 30 days). No statistically significant
differences were noted between MD and CSS at the two
different times (Table 2). This did not occur with unstable
patients (Table 2). Among the stable patients, the symptom
domain (SD) showed a stronger negative correlation with
the CSS (rs = 0.527 at TA and rs = 0.574 at TB). Statistical
significance was observed for the other domains, but at
lower levels.
The assessment of responsiveness by comparing MD
at two different times showed statistically significant
differences in all of them, and the same occurred with the
CSS (Table 2).
The evaluation of the relationship between CSS and MD
of the PAQLQ-A in unstable patients is shown in Table 3,
wherein only the SD revealed a stronger correlation in both
time periods (rs =  0.488 at TA and rs =  0.574 at TB). No
statistically significant values were observed for the other
domains, except for the overall score at TB.
The reliability of the PAQLQ-A and its internal consistency
were assessed by Cronbachs alpha coefficient for stable
and unstable patients, yielding values of 0.923 and 0.869
respectively, and of 0.909 when they were assessed together,
regardless of their clinical stability (Table 4).
Discussion
The assessment of asthma using only clinical
parameters, such as pulmonary function testing, use of
medications for symptom relief, intensity and severity of
symptoms and airway response to methacholine, to
carbachol and to cold, allow determining its severity and
defining a treatment plan.19
Based on epidemiological studies, on the cost analysis
and on the assessment of social and psychological aspects
involved in asthma, it was hypothesized that the clinical
assessment of asthma  was indeed just one facet of the
great impact it had on patients lives and on society. Since
the 1980s, the assessment of QoL has played a key role in
the treatment and follow-up of asthmatic patients, and the
term QoL has become a constant characteristic in the daily
life of any individual.21
Studies on health-related QoL (general and specific)
have enabled the development of tools that are able to
assess asthmatic patients in an appropriate manner. The
need for a specific tool to assess QoL in asthma has arisen
from some peculiarities of this disease. First, because it is
an episodic disease, and when properly controlled, the
patient may stay asymptomatic for some time; otherwise,
the patient may have extremely severe episodes. Moreover,
acute exacerbations may be triggered off according to the
season of the year or due to the presence of indoor or
environmental allergens. For that reason, in order to assess
QoL it is necessary to conduct longitudinal studies and to
add questions related to past events (past week, past
month, for instance), and to try to determine the intensity
Table 2 - Mean and median for each of the domains:symptoms (MSD), emotional function (MED), activity
(MAD), overall score and clinical severity score (CSS) at two different times TA and TB (at intervals
of 15 to 30 days)
* Wilcoxon’s test.
Stable Unstable  
Mean Median p Mean Median p
MSD TA 6.60 6.23 0.889 5.85 5.64 0.012 *
MSD TB 6.70 6.15 6.80 6.43
MED TA 6.63 6.22 0.250 6.25 5.82 0.003 *
MED TB 6.88 6.41 7.00 6.68
MAD TA 6.40 5.59 0.067 5.70 4.86 0.005 *
MAD TB 6.50 5.97 6.50 6.11
Overall TA 6.36 6.01 0.116 5.81 5.44 0.001 *
Overall TB 6.49 6.18 6.73 6.43
CSS TA 1.0 1.3 0.073 3.0 3.4 0.001 *
CSS TB 1.0 1.1 0.5 1.0
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and frequency of symptoms or another evaluated parameter.
Furthermore, the treatment of asthma has a weaker effect
on the QoL; therefore, it is necessary to have more sensitive
measures to assess such impact or to analyze a larger
patient population.22
Based on these data, questionnaires were devised to
assess the QoL in asthmatic patients. According to some
researchers, the assessment of QoL in affected children
must be carried out with the children themselves and not
with their parents or surrogates, since the latter may not
appropriately perceive how their childs QoL is
impaired.3,22-24 The questionnaires applied to children
work better when the perceptions of children and their
parents are assessed separately.
The PAQLQ was chosen among several questionnaires
for the assessment of QoL in children because, in our
opinion, it contains important and crucial aspects for the
proper assessment of QoL in these patients. It proved
useful in assessing physical (symptom and activity
domains) and psychological (emotional domain) aspects.
In addition, the PAQLQ was validated in its country of
origin (Canada) and in many other countries, including
those of Latin origin.3,14,16,17
Patients Simple measure Intraclass Cronbachs alpha
intraclass  measure reliability coefficient
All (95%CI) 0.303 * (0.227-0.404) 0.909 * (0.871-0.939) 0.909
Stable (95%CI) 0.343 * (0.256-0.455) 0.923 * (0.888-0.951) 0.923
Unstable (95%CI) 0.224 (0.132-0.382) 0.869 * (0.776-0.934) 0.869
Table 4 - Reliability coefficient (with 95% confidence interval) in all patients (stable and unstable) and
alpha values
* p < 0.001.
CI = confidence interval.
Another reason for choosing this questionnaire was that
PAQLQ-A is quick and easy to use. It took from 10 to 15
minutes to be applied, depending on the childs intellectual
capacity and level of education, as well as on the time of the
interview (the first interview usually was longer and the last
one shorter). This finding was consistent with reports on the
original and adapted questionnaires.13,14,16,17
The application of the PAQLQ-A in children aged 7 or 8
years was not an easy task, since, contrary to what occurred
in other places where it had been validated, Brazilian
children this age sometimes are not literate, and when they
are, they have such a poor cultural level that they cannot
understand the meaning of moderately, frustrated or
uncomfortable. In this case, the terms were defined
according to the standard Brazilian Portuguese dictionary so
as to avoid information bias during data collection. With
regard to other ages, there were no problems with the
application of the questionnaire.
In our opinion, the exclusion of patients who were not
able to read or who abandoned the study cannot be
characterized as a selection bias (the association between
exposure and outcome observed in the studied population
is different from that which would be noted if all eligible
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Table 3 - Relationship between clinical severity score (CSS) and mean score for each of the domains
(MD): symptoms (MSD), emotional function (MED), activity (MAD), and overall score at two
different times TA and TB - Spearmans correlation coefficient (rs), in terms of patients clinical
stability
Stable Unstable
rs p rs p
CSS TA x MSD TA -0.527 < 0.001 -0.488 < 0.05
MED TA -0.289 < 0.05 -0.393 0.07
MAD TA -0.398 < 0.01 -0.158 0.483
Overall TA -0.458 < 0.01 -0.380 0.081
CSS TB x MSD TB -0.574 < 0.01 -0.574 < 0.01
MED TB -0.465 < 0.01 -0.399 0.06
MAD TB -0.477 < 0.01 -0.414 0.05
Overall TB -0.571 < 0.01 -0.470 < 0.05
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subjects had been studied),25 since all patients were
previously admitted to the study, but were excluded due to
some setback. On the other hand, if we had included those
patients who were not able to understand the questionnaire
properly, we could have had a wrong impression about the
analyzed questionnaire (information bias).25
Male predominance (1.24:1) was merely casual and had
already been described by other authors in different
studies.26,27
The prevalence of children with moderate persistent
asthma in our sample (67.8%), comparatively to patients
with mild intermittent asthma (14.3% both), reflects the
situation in our setting, that is, a tertiary care hospital that
only treats the most severe cases. However, only two
patients with severe persistent asthma (3.6%) were included
in the study, as severely ill patients are usually being
treated with oral corticosteroids or immunosuppressive
drugs, have some laboratory or anatomical pulmonary
findings, or are still being investigated.
The reproducibility of the PAQLQ-A was assessed by
applying the questionnaire to stable patients at two different
times. No statistically significant difference was noted
between the mean score for each of the domains in any of
the time periods, that is, the score at TA was exactly the
same one found at TB (Table 2). The CSS also was
reproducible, since it did not vary over time. These findings
allow us to conclude that the questionnaire is reproducible,
that is, it yielded the same results after several applications
to patients who showed no relevant difference.28
Another way to verify the reproducibility of the
questionnaire was to use correlation coefficients, as the one
proposed by Kirshner and Guyatt.29 Table 3 shows the
correlation between the CSS at TA and TB and the mean
score for each of the domains at the same times.
We observed a strong negative significant correlation in
the SD (rs = -0.527 at TA; rs = -0.574 at TB); in the other
domains, the correlation was significant, but weak. Since
the SD is more objective, it is probably more easily understood
and more closely related to the patients clinical status, thus
showing a stronger correlation between CSS and MD.
The responsiveness was determined by studying unstable
patients.28 Table 5 compares the MD and CSS in each time
period separately. The statistical analysis of both groups
revealed statistically significant differences between the
assessed parameters at TA and TB for all the items analyzed.
Spearmans correlation test was used to assess the
presence of some correlation between the CSS and MD, in
each time period, separately. The MSD (TA and TB) and MAD
(TB) had a statistically significant correlation (Table 3). This
way, we showed that the PAQLQ-A assesses what it is
supposed to; however, the weak correlation with clinical
parameters may be a consequence of the small sample size.
General measures such as apparent validity and content
validity were observed in the PAQLQ-A, which means that
this questionnaire was able to assess QoL; besides, it also
established a close relationship with the limitations imposed
on an individual by the disease (content validity).
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